Response to Letters regarding "Risk and Benefit of mRNA COVID-19 Vaccines for the Omicron Variant by Age, Sex, and Presence of Comorbidity: A Quality-Adjusted Life Years Analysis"

Am J Epidemiol. 2023 Dec 19:kwad243. doi: 10.1093/aje/kwad243. Online ahead of print.NO ABSTRACTPMID:38115177 | DOI:10.1093/aje/kwad243

Source: Am J Epidemiol - December 20, 2023 Category: Epidemiology Authors: Taito Kitano Matthew Z Dudley Lilly Engineer David A Thompson Daniel A Salmon Source Type: research